Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001597143-14-000002
Filing Date
2014-06-19
Accepted
2014-06-19 17:12:46
Documents
1
Effectiveness Date
2014-06-19
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 12191
  Complete submission text file 0001597143-14-000002.txt   13384
Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences III, L.P. (Filer) CIK: 0001597143 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1214
Type: D/A | Act: 33 | File No.: 021-211426 | Film No.: 14930989